AI-powered X-ray technology developed by M42, an Abu Dhabi-based health company, is revolutionizing the process of tuberculosis (TB) screenings. The technology, called AIRIS-TB, has been tested in over 1 million scans at the Capital Health Screening Centre (CHSC) and has shown promising results. The tool can reduce radiologist workload by up to 80% while ensuring accurate detection of TB cases. This automation will allow the facility to serve a larger number of visa applicants efficiently. The AI system detects abnormalities in X-rays and streamlines the screening process, leading to improved health outcomes and a faster turnaround time for visa applicants.
The implementation of AIR-TB is set to reshape healthcare delivery and the screening experience by leveraging advanced AI technology. By automating the screening process, radiologists can focus on detecting other conditions and providing follow-up care for patients. This tool is not only a technological advancement but also a step towards setting new global standards in TB screening. M42 aims to deploy AIRIS-TB on Malaffi, Abu Dhabi’s Health Information Exchange, making it accessible to other screening providers in the region. This move signifies a significant advancement in medical technology within the UAE.
The CEO of Capital Health Screening Centre, Ali Alsaffar, emphasized the potential of AIRIS-TB in improving patient care and overall efficiency in healthcare operations. The tool’s deployment at the flagship visa screening facility is a significant milestone in medical technology within the UAE. With a focus on patient care and diagnostic precision, the implementation of AIRIS-TB in various healthcare facilities is expected to enhance efficiency and provide better care to patients. This technology has the potential to redefine the standards and process of TB screening globally, ensuring accurate and timely detection of cases.
M42’s commitment to enhancing AIRIS-TB’s capabilities and exploring its applications in other diagnostic areas highlights the company’s dedication to innovative healthcare solutions. The scalable model of AIRIS-TB allows for extended use in other medical facilities, improving screening efficiency and patient care across different sectors. By focusing on technological innovation and advanced AI, M42 aims to address pressing health challenges and set new benchmarks in TB screening and healthcare delivery. The integration of AI technology in healthcare facilities promises improved operational efficiencies and better health outcomes for patients undergoing TB screenings.
In conclusion, the AI-powered X-ray technology developed by M42 is at the forefront of reshaping the healthcare landscape by automating TB screenings and enhancing operational efficiencies in healthcare facilities. The deployment of AIRIS-TB in both CHSC and potentially on Malaffi signifies a significant advancement in medical technology in the UAE. By leveraging advanced AI capabilities, the tool streamlines the screening process, reduces radiologist workload, and improves patient care. With a focus on scalability and innovation, AIRIS-TB is set to redefine the standards and processes of TB screening globally, ensuring accurate and timely detection of cases.
